| |
|
|
|
Cancer Genetics Inc.  
|
|
0.107821 -0.002 (-0.02%) |
08-23 15:59 |
|
Open: |
0.1149 |
Pre close: |
0.11 |
Target:
|
0.17 
|
|
High: |
0.115 |
Low: |
0.1065 |
Resistance:
|
0.14
0.17
|
|
Volume: |
1,628,677 |
Market Cap: |
7M |
Support:
|
0.10
0.08
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.12
|
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
0.13 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
0.18 |
Stochastic Oscillator |
%K(14,3):
|
26.52 |
|
MA(250): |
0.38 |
%D(3): |
33.28 |
|
Average Volume(K) |
3-Month: |
194932
|
52-Week |
High:
|
1.30 |
|
10-Days: |
182846 |
Low: |
0.10 |
|
RSI |
RSI(14):
|
32.13 |
Change(%): |
-89.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.630 |
Return on Equity (ttm) |
-148.1 |
Shares Out. (M) |
27.75 |
|
EPS Est. Current Year |
-0.860 |
Return on Assets (ttm) |
-23.4 |
Shares Float (M) |
47.27 |
|
EPS Est. Next Year |
-0.260 |
PEG Ratio |
0.00 |
% Held by Insiders |
24.60 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
-10.8 |
% Held by Institutions |
13.41 |
|
Forward EPS |
-0.290 |
Gross Profit (p.s.) |
0.315 |
Shares Short (K) |
2790 |
|
Book Value (p.s.) |
0.140 |
EBITDA (p.s.) |
-0.505 |
P/E |
-0.17 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.77 |
|
Profit Margin |
-77.07 |
Operating Cash Flow
(M) |
-12.54 |
P/S |
3693867.50 |
|
Operating Margin |
-59.74 |
Levered Free Cash Flow
(M) |
0.33 |
P/CF |
-0.24 |
|
|
|
|
|
|
